Zn(II)/pyridyloxime complexes as potential reactivators of OP-inhibited acetylcholinesterase: in vitro and docking simulation studies.

In order to investigate the ability of metal complexes to act as reactivators of organophosphorus compounds (OP)-inhibited acetylcholinesterase (AChE), we have synthesized and crystallographically characterized three novel mononuclear Zn(II) complexes formulated as [ZnCl2{(4-py)CHNOH}2] (1), [ZnBr2{(4-py)CHNOH}2] (2) and [Zn(O2CMe)2{(4-py)CHNOH}2]∙2MeCN (3∙2MeCN), where (4-py)CHNOH is 4-pyridinealdoxime. Their reactivation potency was tested in vitro with a slight modification of the Ellman's method using Electric eel acetylcholinesterase and the insecticide paraoxon (diethyl 4-nitrophenyl phosphate) as inhibitor. The activity of the already reported complex [Zn2(O2CPh)2{(4-py)CHNOH}2]·2MeCN (4·2MeCN) and of the clinically used drug obidoxime 1,1'-[oxybis(methylene)]bis{4-[(E)- (hydroxyimino)methyl]pyridinium} was also examined. The results of the in vitro experiments demonstrate moderate reactivation of the metal complexes compared to the drug obidoxime. On the other hand, it is clearly shown that the metal complex is the responsible molecular entity for the observed activity, as the reactivation efficacy of the organic ligand (4-pyridinealdoxime) is found to be inconsequential. Docking simulation studies were performed in the light of predicted complex-enzyme interactions using the paraoxon-inhibited enzyme along with the four Zn(II) complexes and obidoxime as a reference reactivator. The results showed that the three mononuclear metal complexes possess the required characteristics to be accommodated into the active site of AChE, while the entrance of the dinuclear Zn(II) compound is unsuccessful. An interesting outcome of docking simulations is the fact that the mononuclear compounds accommodate into the active site of AChE in a similar mode as obidoxime.

Investigation of the zinc(II)-benzoate-2-pyridinealdoxime reaction system.

The employment of pyridine-2-carbaldehyde oxime (paoH) in zinc(II) benzoate chemistry, in the absence or presence of azide ions, is described. The syntheses, crystal structures and spectroscopic characterization are reported for the complexes [Zn(O(2)CPh)(2)(paoH)(2)] (1), [Zn(12)(OH)(4)(O(2)CPh)(16)(pao)(4)] (2) and [Zn(4)(OH)(2)(pao)(4)(N(3))(2)] (3). The Zn(II) centre in octahedral 1 is coordinated by two monodentate PhCO(2)(-) groups and two N,N'-chelating paoH ligands. The metallic skeleton of 2 describes a tetrahedron encapsulated in a distorted cube. The {Zn(12)(µ-OH)(4)(µ(3)-ΟR)(4)}(16+) core of the cluster can be conveniently described as consisting of a central {Zn(4)(µ(3)-ΟR)(4)}(4+) cubane subunit (RO(-) = pao(-)) linked to four {Zn(2)(µ-OH)}(3+) subunits via the OH(-) group of each of the latter, which becomes µ(3). The molecule of 3 has an inverse 12-metallacrown-4 topology. Two triply bridging hydroxido groups are accommodated into the metallacrown ring. Each pao(-) ligand adopts the η(1) : η(1) : η(1) : µ coordination mode, chelating one Zn(II) atom and bridging a Zn(II)(2) pair. Complexes 1 and 2 display photoluminescence with maxima at ∼355 nm and ∼375 nm, upon maximum excitation at 314 nm; the origin of the photoluminescence is discussed.

Synthesis, Crystal Structures, and DNA Binding Properties of Zinc(II) Complexes with 3-Pyridine Aldoxime.

The employment of 3-pyridine aldoxime, (3-py)CHNOH, in Zn(II) chemistry has afforded two novel compounds: [Zn(acac)(2){(3-py)CHNOH}]·H(2)O (1·H(2)O) [where acac(-) is the pentane-2,4-dionato(-1) ion] and [Zn(2)(O(2)CMe)(4){(3-py)CHNOH}(2)] (2). Complex 1·H(2)O crystallizes in the monoclinic space group P2(1)/n. The Zn(II) ion is five-coordinated, surrounded by four oxygen atoms of two acac(-) moieties and by the pyridyl nitrogen atom of the (3-py)CHNOH ligand. Molecules of 1 interact with the water lattice molecules forming a 2D hydrogen-bonding network. Complex 2 crystallizes in the triclinic P-1 space group and displays a dinuclear paddle-wheel structure. Each Zn(II) exhibits a perfect square pyramidal geometry, with four carboxylate oxygen atoms at the basal plane and the pyridyl nitrogen of one monodentate (3-py)CHNOH ligand at the apex. DNA mobility shift assays were performed for the determination of the in vitro effect of both complexes on the integrity and the electrophoretic mobility of pDNA.

Synthesis, X-Ray Structure, and Characterization of Catena-bis(benzoate)bis{N,N-bis(2-hydroxyethyl)glycinate}cadmium(II).

The reaction of N, N-bis(2-hydroxyethyl)glycine (bicine; bicH(3)) with Cd(O(2)CPh)(2) · 2H(2)O in MeOH yielded the polymeric compound [Cd(2)(O(2)CPh)(2)(bicH(2))(2)](n)(1). The complex crystallizes in the tetragonal space group P4(1)2(1)2. The lattice constants are a = b = 12.737(5) and c = 18.288(7) Å. The compound contains chains of repeating {Cd(2)(O(2)CPh)(2)(bicH(2))(2)} units. One Cd(II) atom is coordinated by two carboxylate oxygen, four hydroxyl oxygen, and two nitrogen atoms from two symmetry-related 2.21111 (Harris notation) bicH(2) (-) ligands. The other Cd(II) atom is coordinated by six carboxylate oxygen atoms, four from two bicH(2) (-) ligands and two from the monodentate benzoate groups. Each bicinate(-1) ligand chelates the 8-coordinate, square antiprismatic Cd(II) atom through one carboxylate oxygen, the nitrogen, and both hydroxyl oxygen atoms and bridges the second, six-coordinate trigonal prismatic Cd(II) center through its carboxylate oxygen atoms. Compound 1 is the first structurally characterized cadmium(II) complex containing any anionic form of bicine as ligand. IR data of 1 are discussed in terms of the coordination modes of the ligands and the known structure.

A tetrahedron in a cube: a dodecanuclear Zn(II) benzoate cluster from the use of 2-pyridinealdoxime.

The reactions of 2-pyridinealdoxime with Zn(O(2)CPh)(2)·2H(2)O have led to a mononuclear complex and a dodecanuclear cluster; the Zn(12) compound, whose metallic skeleton describes a tetrahedron encapsulated in a distorted cube, is the biggest Zn(II) oxime cluster discovered to date and displays photoluminescence with a maximum at 354 nm upon maximum excitation at 314 nm.

Diorganotin(IV) complexes of dipeptides containing the alpha-aminoisobutyryl residue (Aib): preparation, structural characterization, antibacterial and antiproliferative activities of [(n-Bu)2 Sn(H(-1)L)] (LH=H-Aib-L-Leu-OH, H-Aib-L-Ala-OH).

Two new organotin(IV) complexes with dianionic dipeptides containing the alpha-aminoisobutyryl residue (Aib) as ligands are described. The solid complexes [(n-Bu)(2)Sn(H(-1)L(A))] x 2MeOH (1 x 2MeOH) (L(A)H=H-Aib-L-Leu-OH) and [(n-Bu)(2)Sn(H(-1)L(B))] x MeOH (2 x MeOH) (L(B)H=H-Aib-L-Ala-OH) have been isolated and characterized by single-crystal X-ray crystallography and spectroscopic techniques (H(-1)L(2-) is the dianionic form of the corresponding dipeptide). Complexes 1 x 2MeOH and 2 x MeOH are monomeric with similar molecular structures. The doubly deprotonated dipeptide behaves as a N(amino), N(peptide), O(carboxylate) ligand and binds to the Sn(IV) atom. The five-coordinate metal ion has a distorted trigonal bipyramidal geometry. A different network of intermolecular hydrogen bonds in each compound results in very dissimilar supramolecular features. The IR, far-IR, Raman and (119)Sn NMR data are discussed in terms of the nature of bonding and known structures. The antibacterial and antiproliferative activities as well as the effect of the new compounds on pDNA were examined. Complexes 1 and 2 are active against the gram-positive bacteria Bacillus subtilis and Bacillus cereus. The IC(50) values reveal that the two compounds express promising cytotoxic activity in vitro against a series of cell lines.

Dinuclear versus tetranuclear cluster formation in zinc(II) nitrate/di-2-pyridyl ketone chemistry: synthetic, structural and spectroscopic studies.

The use of di-2-pyridyl ketone, (py)2CO, in zinc(II) nitrate chemistry has yielded a dinuclear complex and a cationic tetranuclear cluster. The 1:1 Zn(NO3)2.4H2O/(py)2CO reaction system in EtOH gives [Zn2(NO3)2{(py)2C(OEt)O}2].0.5H2O (1.0.5H2O), whereas the same reaction system in MeCN yields [Zn4(NO3)3{(py)2C(OH)O}4(H2O)](NO3) (2). The monoanionic derivatives of the hemiacetal and the gem-diol forms of di-2-pyridyl ketone have been derived from the ZnII-mediated addition of solvent (EtOH, H2O involved in MeCN) on the carbonyl group of (py)2CO. Each (py)2C(OEt)O- ion functions as an eta1:eta2:eta1:mu2 ligand in 1.0.5H2O chelating the two ZnII atoms through the 2-pyridyl nitrogen atoms and the common bridging, deprotonated oxygen atom; one asymmetric chelating nitrate completes six coordination at each metal center. The tetranuclear cluster cation of 2 has a cubane topology with the ZnII ions and the deprotonated oxygen atoms from the four eta1:eta3:eta1:mu3 (py)2C(OH)O- ligands occupying alternate vertices. Three monodentate nitrates and one aqua ligand complete the sixth coordination site at the metal ions. The two complexes have been characterized by IR and far-IR spectroscopies. Characteristic bands are discussed in terms of the known structures and the coordination modes of the nitrato ligands. Upon excitation at 371 nm, complex 2 displays blue photoluminescence in the solid state at room temperature with two emission maxima at 430 and 455 nm.

Dipeptides containing the alpha-aminoisobutyric residue (Aib) as ligands: preparation, spectroscopic studies and crystal structures of copper(II) complexes with H-Aib-X-OH (X=Gly, L-Leu, L-Phe).

Synthetic procedures are described that allow access to new copper(II) complexes with dipeptides containing the alpha-aminoisobutyric residue (Aib) as ligands. The solid complexes [Cu(H(-1)L(A))](n).nH(2)O (1) (L(A)H=H-Aib-Gly-OH), [Cu(H(-1)L(B))(MeOH)](n).nMeOH (2) (L(B)H=H-Aib-L-Leu-OH) and [Cu(H(-1)L(C))](n) (3) (L(C)H=H-Aib-L-Phe-OH) have been isolated and characterized by single-crystal X-ray crystallography, solid-state IR spectra and UV-Vis spectroscopy in solution (H(-1)L(2-) is the dianionic form of the corresponding dipeptide). Complexes 1 and 3 are three-dimensional coordination polymers with similar structures. The doubly deprotonated dipeptide behaves as a N(amino), N(peptide), O(carboxylate), O'(carboxylate), O(peptide) mu(3) ligand and binds to one Cu(II) atom at its amino and peptide nitrogens and at one carboxylate oxygen, to a second metal at the other carboxylate oxygen, while a third Cu(II) atom is attached to the peptide oxygen. The geometry around copper(II) is distorted square pyramidal with the peptide oxygen at the apex of the pyramid. The structure of 2 consists of zigzag polymeric chains, where the doubly deprotonated dipeptide behaves as a N(amino), N(peptide), O(carboxylate), O'(carboxylate) mu(2) ligand. The geometry at copper(II) is square pyramidal with the methanol oxygen at the apex. The IR data are discussed in terms of the nature of bonding and known structures. The UV-Vis spectra show that the solid-state structures of 1, 2 and 3 do not persist in H(2)O.